DOSSIER · 13F Holders · Q1 2026Healthcare · Drug Manufacturers - GeneralInflation hedgeYield
JNJ
JOHNSON & JOHNSON
4,847 institutions still hold JOHNSON & JOHNSON as of Q1 2026. Tracked across SEC 13F-HR filings, with insider and 13D/G activity surfaced alongside.
CUSIP 478160104·Drug Manufacturers - General·4,847 13F holders·last filed Mar 31, 2026
AI Holders Summary · Q1 2026
JNJ registers 4,470 institutional filers with roughly $419B in aggregate 13F value. The register is thick with passive-and-healthcare-allocator overlap: BlackRock, Vanguard, State Street, and FMR anchor the top tier, while active healthcare managers like Capital Research Global Investors and Wellington Management maintain meaningful stakes. The defining JNJ signal is not dramatic rotation but breadth: the number of sustained holders across the active and passive layers makes JNJ one of the most durable institutional healthcare names.
Top holders
Sorted by position value. Source: SEC EDGAR 13F-HR filings.
Page 1 of 243
4827 more holders available. Log in →